A LightCycler and two TaqMan real-time PCR assays were evaluated against an older PCR with liquid-phase hybridization method for the detection of enterovirus RNA in 74 patient samples. The two-step LightCycler and the two-step TaqMan formats correlated well with each other (r 2 ‫؍‬ 0.90) and were equally sensitive compared to the liquid-phase hybridization method, whereas the one-step recombinant Tth DNA polymerase format was rather insensitive, detecting enterovirus RNA in only about one-half of those patient samples previously positive by liquid-phase hybridization. The two-step TaqMan method was optimized utilizing 10 l of cDNA and demonstrated the highest degree of analytical sensitivity among the methods evaluated in our study, being able to reproducibly quantify down to 510 copies of enteroviral RNA/ml of cerebrospinal fluid. This new assay can be performed in 4 h, is much less labor intensive, and showed less cross-reactivity with rhinovirus than the liquid-phase hybridization assay. Thus, the two-step TaqMan assay should prove useful in the diagnosis of enteroviral meningitis versus bacterial meningitis, thereby resulting in timely and appropriate clinical management that can amount to significant cost savings to the patient and health care system.
FIG. 1. Enterovirus sequence alignments for 5Ј primer, 3Ј primer, and probe regions. The 14 most clinically important enterovirus serotypes were determined, and sequences from the primer and probe binding sites were aligned using GeneDoc version 2.6.2. Shown for each region is the consensus sequence, any serotypes varying from the consensus sequence, and the alignment and sequences of primers and probes previously described in the literature. , identical base; ■, 
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tion method utilized the 5Ј upstream primer previously described by Rotbart in 1990 and a slightly modified probe based on that reported in the same study (21) . For our real-time assays, we selected the 5Ј primer and probe derived from the work of Verstrepen (30) , since their T m s most closely matched suggested TaqMan primer and probe conditions. The TaqMan probe was labeled with FAM at the 5Ј end and TAMRA at the 3Ј end. For rhinovirus detection, the liquid-phase hybridization probe was 5Ј-TAG TTG GTC CCA TCC CG-3Ј. For the one-and two-step TaqMan assays, the forward enterovirus primer concentration was 300 nM, the reverse primer concentration was 900 nM, and the probe concentration was 150 nM for the one-step assay and 100 nM for the two-step assay. For the LightCycler method, the forward primer concentration was 150 nM, the reverse primer concentration was 450 nM, and the probe concentration was 150 nM. Liquid-phase hybridization assay. For DNA amplification, 10 l of cDNA was added to 90 l of master mix (final concentrations of 16.6 M reverse primer, 16.6 M forward primer, 1ϫ PCR buffer, 214.6 M dATP, dCTP, and dGTP, 429.3 M dUTP, 22 U of AmpliTaq/ml, including 10 l of glycerol). Mixes were amplified using a Perkin-Elmer 9600 thermal cycler as follows: 2 min at 94°C; 35 cycles of 30 s at 96°C, 30 s at 54°C, and 30 s at 72°C; and then 5 min at 72°C for final terminal extension. Following PCR amplification, liquid-phase hybridization was done by adding 3.9 l of amplified product to 10 l of hybridization mix (final concentrations of 200 M NaCl, 100 M [each] deoxynucleoside triphosphates [A, T, G, and C], 0.02% bromophenol blue in formamide, 0.01 M formamide, and 10 6 cpm of 32 P-labeled virus-specific probe ranging from 3 to 100 nM and labeled using T4 polynucleotide kinase and [␥-
32 P]ATP). The samples were then placed in the Perkin-Elmer 9600 thermal cycler, heated to 97°C for 5 min, and then slowly cooled to 20°C over 15 min. Radiolabeled hybridized amplicon product was then detected by loading 10 l of each sample on 6% acrylamide gels (Invitrogen, Carlsbad, Calif.). Gel electrophoresis was done at 180 V for 20 to 30 min. The gel was then placed on blotting paper and dried on a gel dryer. Kodak X-Omat film was then exposed overnight at room temperature or at Ϫ70°C for 2 h.
One-step RT-PCR assay. The one-step RT-PCR test was performed using the EZ RT-PCR kit (no. 403028; Applied Biosystems, Foster City, Calif.) that utilizes rTth DNA polymerase. The master mix was prepared according to the package insert instructions, and then 3 l of purified RNA from each sample was mixed with 47 l of master mix. Samples were analyzed on the ABI 7700 sequence detection system (Applied Biosystems). Cycling parameters were 2 min at 50°C, 30 min at 60°C, 5 min at 95°C, and then 45 cycles of 20 s at 95°C followed by 1 min at 62°C.
Second-step PCR with ABI 7700. The second-step PCR was performed on the ABI 7700. Either 3 l or 10 l of cDNA was added to an in-house prepared master mix (12) . Cycling parameters were 2 min at 50°C, 2 min at 95°C, then 45 cycles of 20 s at 95°C followed by 1 min at 60°C.
Second-step PCR with LightCycler. The second-step PCR was performed on the Roche LightCycler using the FastStart LC DNA hybridization probes kit (Roche Molecular Biochemicals, Indianapolis, Ind.). The master mix was prepared according to the package insert instructions, and then 17 l was added to 3 l of sample cDNA. The concentration of MgCl 2 was 5 mM. Samples were placed in capillary tubes and then subjected to 40 cycles of amplification at 95°C for 10 s and then 60°C for 13 s.
Enterovirus standard materials. Two lots of enterovirus Armored RNA containing 5Ј untranslated region sequence from enterovirus were used for standard preparation, a custom preparation of 154 bp (2.0 ϫ 10 13 copies/ml) and a newer commercial preparation of 263 bp (Ambion RNA Diagnostics, Austin, Tex.). The custom preparation was purchased in 1998 and had been stored for 5 years at Ϫ70°C. The two lots of Armored RNA performed equally when they were used to create standard curves of 8.7 ϫ 10 7 , 8.7 ϫ 10 5 , 8.7 ϫ 10 3 , and 8.7 ϫ 10 2 copies/ml for the real-time assays. For routine assays, the 8.7 ϫ 10 7 -copies/ml standard was prepared in batches (either RNA or cDNA) from the custom preparation, which was purchased in 1998. The 8.7 ϫ 10 5 -, 8.7 ϫ 10 3 -, and 8.7 ϫ 10 2 -copies/ml standards were prepared from the 8.7 ϫ 10 7 -copies/ml standard daily by dilution in Tris buffer (10 mM, pH 8.0). For studies to determine the assay's analytical sensitivity, a 1:1.7 dilution of the 870-copies/ml standard was made daily to produce a sample containing 510 copies/ml, and this sample was run in quadruplicate wells on seven consecutive runs. Initial evaluation of the real-time assays was done using dilutions of aliquots of 1.0 ϫ 10 6 copies of enterovirus Armored RNA material/ml originally prepared by dilution of the custom lot and stored at Ϫ70°C for 2 years. All standards were assayed in duplicate for generation of the standard curve.
Enterovirus control materials. Cox B5 culture fluid derived from a patient isolate previously typed by direct fluorescent antibody was used to make high and low enterovirus controls. The high enterovirus control with a mean concentration of 3.3 ϫ 10 6 copies/ml was stored at Ϫ70°C in 250-l aliquots, whereas the low control, with a mean concentration of 2.2 ϫ 10 3 copies/ml, was prepared daily by dilution of the high control. For studies to determine the assay's analytical sensitivity, a 1:4 dilution of the low control was made daily to produce a sample containing 550 copies/ml, and this sample was run in quadruplicate wells on seven consecutive runs. For routine runs, high and low controls were run in duplicate.
Computer analysis tools. T m s of primers and probes were determined using Oligo Melting Temperature version 5.0 (http://blocks.fhcrc.org/oligo_melt.html) (3, 24) . Enterovirus and rhinovirus sequences were retrieved from the GenBank database of the National Center for Biotechnology Information (http://www .ncbi.nlm.nih.gov/) by a Taxonomy search and used to create two data files. For both databases, sequences containing either 5Ј untranslated region or the entire genomic sequence were retrieved. To simplify alignment and analysis, the first 70 to 100 bp and all base pairs past bp 700 were deleted to isolate sequence in the area of interest. Alignments of sequences were done with GeneDoc software version 2.6.2, available through the Pittsburgh Supercomputing Center (http: //www.psc.edu/biomed/genedoc/).
RESULTS

Bioinformatics analysis of candidate primers and probes.
More than 60 distinct serotypes of human enteroviruses are known to exist. For this reason, only a few of the previously published primer-probe sets have actually been tested in the laboratory for reactivity against all enterovirus serotypes (9, 11, 18, 32). We used a bioinformatics approach in an effort to predict the specificity of the more recently published real-time primers and probes. First, we determined those serotypes of enterovirus most likely to be of clinical relevance, using surveillance reports for the years 1993 to 1999 published by the Centers for Disease Control and Prevention in Morbidity and Mortality Weekly Report (4, 5) . By ranking the serotype frequencies from highest to lowest, the top 14 serotypes for each year from 1 to 14 were determined to be the following: echovirus (Echo) 11, Echo 30, coxsackievirus (Cox) A9, Echo 6, Echo 9, Cox B2, Echo 7, Cox B3, Cox B4, Cox B5, Echo 25, enterovirus 71, Echo 17, and Echo 22. Based on these frequencies, we extracted from GenBank all available sequences up to a total of 6 for each of these serotypes and created a database with 45 sequences. We then determined the degree of matching with previously published primers and probes.
Significant homology in the primer and probe sequence regions was observed with all serotypes in the database (Fig. 1) . Most published primer and probe sequences for detection of enterovirus were found to amplify very similar sequences within the 5Ј untranslated region of the virus. Essentially all sequences in the database would be predicted to amplify with most published primer and probe sets. However, because of some base pair differences and some significant T m differences, not all primer and probe sets would be predicted to amplify all sequences or work with all methodologies. Based on the alignment information and the T m constraints of primer and probe design for real-time PCR, for further development we selected the Verstrepen 5Ј primer and probe (30) to be used in conjunction with the Rotbart 1990 3Ј primer (21) .
Our analysis revealed that two of the Echo 6 sequences in our initial database had C-to-T changes at the 3Ј end of the 5Ј primer sequence (position 479). This mismatch may lead to decreased or absent amplification of Echo 6 viruses possessing this C-to-T change. To evaluate the frequency of this C-to-T change, we extracted all Echo 6 sequences available in GenBank. Of the 12 available sequences, 3 had the C-to-T change, while the remaining 9 had the common C. Thus, based on alignment data, we would predict that the selected primer and probe sequence should amplify most Echo 6 viruses and nearly all of the most clinically relevant enterovirus sequences.
As a complementary approach, we then checked our primer and probe sequences against all sequences in GenBank using Taxonomy BLAST analysis. Compared to the 5Ј primer used in our earlier liquid hybridization assay, the real-time 5Ј primer identified more identical sequences (513 versus 413). Similarly, the real-time probe identified more identical sequences than did the earlier liquid hybridization probe (363 versus 344). BLAST searches using the real-time 5Ј primer identified sequences for all enterovirus serotypes. For several enterovirus serotypes (serotypes 13, 14, 15, 16, 17, 20, 21, 24, 29, 31, 32 , and 33), sequence information is not available for the binding region for the 3Ј primer and probe. However, based on the Taxonomy BLAST searches done with the remaining serotypes, we would predict that the various enterovirus serotypes should have very similar sequences in the 5Ј primer, 3Ј primer, and probe areas. Therefore, assays with the new primer-probe set would be expected to detect nearly all enterovirus serotypes.
The rhinoviruses are genetically very similar to the enteroviruses, and thus, cross-reactivity is common between these viruses. We therefore performed a similar analysis of our primers and probe using rhinovirus sequences from GenBank. Significantly fewer rhinovirus sequences were present in GenBank, and only 53 sequences included the 5Ј untranslated region bound by our primers and probe. Of these 53 sequences, only 21 had serotype identification, and only 16 of the possible 110 serotypes were represented. We compared all available rhinovirus sequences with those of our chosen enterovirus primers and probe. After alignment of the rhinovirus sequences, areas of sequence similarity to our enterovirus primers and probe were identified at bp 453 to 471, 536 to 563, and 578 to 597 (Fig. 2) . At the site of the enterovirus 3Ј primer similarity, all but one rhinovirus sequence (serotype 1B) would be expected to prime. At the probe site, essentially all amplified sequences should be detected. However, at the 5Ј primer site, most rhinovirus sequences had CCT at the 3Ј end. In contrast, the primer and six sequences, two of which were serotype 87, had TCC. This mismatch between the primer and the majority of rhinovirus sequences would be expected to result in a lack of priming with most rhinoviruses. Thus, based on this rhinovirus alignment analysis, the majority of rhinovirus sequences should not be amplified by the primer-probe set because of mismatching with the 5Ј primer.
One-step real-time RT-PCR assay: sensitivity. We then utilized the Verstrepen 5Ј primer and probe (30) and the Rotbart 1990 3Ј primer (21) to evaluate a one-step real-time RT-PCR assay using rTth DNA polymerase. The one-step real-time RT-PCR method was used to determine the endpoint sensitivity for a Cox B5 culture and an enterovirus Armored RNA stock preparation. By culture, the Cox B5 fluid was positive to a dilution of 10 Ϫ7 , while by our older liquid hybridization method, it was positive to a dilution of 10 Ϫ8 . However, when the Cox B culture fluid sample was tested by the rTth assay method, the Cox B5 fluid was positive only to a 10 Ϫ5 dilution. The control Armored RNA preparation was positive only to a 10 Ϫ2 dilution, implying a detection limit of approximately 1.0 ϫ 10 4 copies/ml. The rTth method was then used to analyze the RNA preparations isolated from 60 patient samples. Of the 21 samples previously positive for enterovirus by liquid-phase hybridization, only 11 were positive by this one-step real-time method. These data indicate that this one-step real-time assay is clearly not as sensitive as our existing liquid-phase hybridization assay. Two-step real-time assays: sensitivity. We next evaluated two separate two-step real-time PCR assays, both utilizing FIG. 2. Rhinovirus sequences with similarity to enterovirus 5Ј primer, 3Ј primer, and probe regions. All rhinovirus sequences containing the 5Ј untranslated region bound by our enterovirus real-time primers and probe were aligned with sequences from our primers and probe using GeneDoc version 2.6.2. Shown for each region is the consensus sequence, any sequences varying from the consensus sequence, and the alignment and sequences of our selected real-time primer-probe set. Superscript a: numbering based on rhinovirus 1B sequence, GenBank accession no. 221708.
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identical primers and probes to amplify cDNA that was prepared from patient RNA using M-MLV. One assay was performed using an in-house prepared master mix (12) with detection by the ABI 7700 (TaqMan), and the other was performed using a Roche DNA amplification kit with detection by the LightCycler. Both assays produced good standard curves with dilutions of enterovirus Armored RNA and had similar threshold cycles (Ct). The LightCycler and ABI 7700 assays yielded identical titers, with the Cox B5 culture positive to a dilution of 10 Ϫ7 and the Armored RNA control solution positive to a dilution of 10 Ϫ5 . Thus, similar sensitivities were seen with the two different reagent/instrument assays, and this sensitivity was 2 to 3 logs better than that observed with the rTth one-step assay. In an effort to maximize sensitivity, we modified the TaqMan assay to use 10 l of cDNA rather than the 3 l used initially. This further improved the TaqMan assay sensitivity by 1 log for both the Cox B5 culture fluid and the Armored RNA control solution.
To determine the sensitivity of our assay, we compared the two-step TaqMan assay using 10 l of sample to the liquidphase hybridization method by evaluating serial threefold dilutions around the endpoint titers of the Cox B5 and Echo 6 culture fluids (Table 1) . These initial results indicated approximately equal sensitivity between the liquid-phase hybridization and TaqMan assays.
To further define the analytical sensitivity of the two-step TaqMan assay, we evaluated standard material with a concentration of 510 copies/ml and Cox B5 control material with a concentration of 550 copies/ml. These dilutions of the standard material and control material were both positive in 28 of 28 wells tested on seven runs, with Ct coefficients of variation (CVs) of 6.1% for the former and 4.6% for the latter. Therefore, we have determined our assay's reproducible lower limit of detection to be 510 copies/ml or better, although positive results with lower concentrations of virus are frequently observed.
Patient sample comparisons. Sixty patient-derived samples were then analyzed by the liquid-phase hybridization assay and both two-step real-time methods, and an additional 14 were evaluated by the two-step real-time methods alone. The twostep real-time assays yielded very similar results for all patient samples, with an r 2 value of 0.90 (Fig. 3) . Dilutions of the culture fluids demonstrated linearity of both real-time assays as well as good correlation between these two methods, from 10 4 to 10 9 copies/ml. In the comparison with the liquid hybridization assay, 24 samples were positive by all three methods, and 36 samples were negative by all three methods. One sample was negative by liquid-phase hybridization but positive repeatedly with both real-time methods. This discrepant sample measured 8.0 ϫ 10 3 copies/ml by TaqMan PCR; it was subsequently cultured, and Cox B3 was found. The positive result for this sample suggests that the primer-probe set utilized in the real-time assays may have a broader reactivity than our earlier primer-probe set for Cox B3. Two-step TaqMan assay: reproducibility. To evaluate the reproducibility of the two-step TaqMan assay over time in a clinical setting, we analyzed quality control data obtained over 1 month as the assay was performed 5 days per week by different medical technologists. The threshold cycles for three of the standard curve points were stable over time, with CVs of 3.5% for the high standard, 2.8% for an intermediate standard, and 2.5% for the low standard (Fig. 4A) . The Ct values for the high and low Cox B5 control samples were also stable over time, with CVs of 2.4 and 7.6%, respectively. The quantitative results had CVs of 37% for the high control and 62% for the low control (Fig. 4B) .
Enterovirus specificity and rhinovirus cross-reactivity. As noted previously, rhinovirus has a genomic structure very similar to that of enterovirus, and thus cross-reactions with enterovirus primer-probe sets are possible. Our previous liquidphase hybridization assay had been shown to give false-positive results with all five of the rhinovirus serotypes (1B, 12, 15, 38, and 56) tested. To investigate cross-reactivity with the TaqMan and liquid-phase hybridization assays, comparison testing was done with American Type Culture Collection rhinoviruses of 18 different serotypes ( Table 2 ). All 18 rhinovirus serotypes were detected by our earlier liquid hybridization enterovirus assay. In contrast, by the TaqMan method, about two-thirds of the rhinovirus serotypes were negative, and only one-third of the serotypes were positive. The positive rhinovirus serotypes appeared to be randomly scattered throughout the Rhinovirus genus and were not associated with rhinovirus receptor subgroups, serotype subgroups, or relatedness of the genetic sequence in the VP4/2 region (25). Overall, the results demonstrated that our real-time TaqMan assay for enterovirus has far less cross-reactivity with rhinoviruses than did our older liquidphase hybridization method.
DISCUSSION
Rapid, accurate diagnosis of enterovirus infection is essential for the appropriate clinical management of patients presenting with meningeal symptoms. Various studies have emphasized the cost savings of up to US $2,700 per patient that can be realized with timely diagnosis of enterovirus infection (20, 28) . In response to this, our laboratory has developed and extensively evaluated a rapid, reproducible two-step real-time quantitative TaqMan PCR assay for the detection of enterovirus RNA in CSF.
We carefully selected primers and a probe for enterovirus based on bioinformatics analysis of the sequences of the 14 most clinically relevant enterovirus serotypes in the United States (4, 5) as well as available rhinovirus sequences. Our analysis and experimental results confirm the sensitivity of the primers and probe for these enterovirus serotypes. Based on our bioinformatics analysis and the similarity of our primers and probe to those used in previous studies evaluating extensive enterovirus panels (18, 19, 31) , the primers and probe used in our study should also be highly sensitive for the detection of other enterovirus serotypes less commonly seen in the clinical setting. It will be important for future studies to validate the selected primer-probe set against the 60-plus enterovirus serotypes, since the potential of such molecular testing to detect serotypes not easily cultured may completely revise our knowledge of the clinical epidemiology of enterovirus serotypes and infection.
Employing this primer-probe combination, we developed and evaluated two rapid two-step real-time PCR methods for the quantification of enterovirus in CSF, one for the ABI 7700 TaqMan platform and the other for the Roche LightCycler platform. The two-step real-time methods were essentially equivalent to each other and to the older liquid-phase hybridization method with respect to sensitivity. All three methods were superior to the one-step RT-PCR method using rTth. The two-step TaqMan method using 10 l of cDNA demonstrated the highest degree of analytical sensitivity, with a lower limit of detection of 510 copies enterovirus/ml of CSF. This degree of analytical sensitivity compares favorably to those of various recently published enterovirus real-time methods, which have suggested sensitivities ranging from 1,250 copies/ml (30) to 3,500 copies/ml (17) . The contrasting insensitivity of the one-step rTth real-time method may be due to disparate efficiencies between the different reverse transcriptase systems used (rTth versus M-MLV) or to inherent differential efficiencies of one-step versus two-step methods. Another study which compared a two-step with a single-step real-time enterovirus method showed that the former could be more sensitive than the later by 3.2 orders of magnitude (7) . To our knowledge, other groups reporting better success with one-step RT-PCR than our group either did not use rTth DNA polymerase (17, FIG. 4 . Quality control data for two-step TaqMan method. Shown are quality control data obtained from 19 runs of the two-step TaqMan method over a 1-month period for high (8.7 ϫ 10 7 copies/ml), intermediate (8.7 ϫ 10 3 copies/ml), and low (8.7 ϫ 10 2 copies/ml) standards (A) and high positive (3.3 ϫ 10 6 copies/ml) and low positive (2.2 ϫ 10 3 copies/ml) controls (B). (19, 31) . Because we were unable to achieve reasonable sensitivity using rTth on the ABI 7700 platform during our initial evaluation, we chose not to further pursue development of the assay using rTth on the LightCycler platform. However, it should be noted that the sensitivity of our two-step TaqMan assay is better than any of the sensitivities reported by others using a one-step approach. Further work will be necessary to evaluate and maximize the efficiency of one-step real-time RT-PCR. The two-step TaqMan assay demonstrated excellent reproducibility over time in a clinical setting with different medical technologists, as indicated by good CVs for Ct results of the standards (3.5% for the high standard, 2.8% for an intermediate standard, and 2.5% for the low standard) which are comparable to those reported by others (17) , as well as by good CVs for quantitative control materials. This suggests good performance over the entire dynamic range of the assay with an upper limit of at least 10 10 copies/ml. The two-step real-time assay's ability to reproducibly quantify enteroviral load over a wide range represents a significant improvement over our previous qualitative liquid-phase hybridization method.
Using our real-time primer-probe set for enterovirus, we observed cross-reactivity with about one-third of the tested rhinovirus serotypes. Cross-reactivity with rhinovirus has also been described for other real-time PCR enterovirus assays (18) . We therefore reviewed our clinical experience regarding enterovirus-rhinovirus cross-reactivity. From 1,205 samples submitted for enterovirus testing during the years 1998 to 2001, 156 (12.9%) were positive by our enterovirus liquid-phase hybridization assay. Of the positives, 83% were CSF specimens and the rest were other sample types. Because of possible cross-reactivity, our laboratory's policy was to routinely retest all positive samples with a rhinovirus-specific probe. Upon retesting using the rhinovirus-specific probe, only 1 of the 156 positive patient-derived specimens proved to contain rhinovirus. This single specimen was a nasal swab. From a clinical standpoint, there have been no published papers reporting isolation of rhinovirus from CSF (19) . Because of the lack of rhinovirus detection in clinical CSF specimens and the much lower rate of cross-reactivity with rhinoviruses using our new real-time TaqMan assay, we have discontinued the confirmatory rhinovirus testing of our clinical samples.
Recently several papers have documented significant cost savings that could potentially be realized by utilizing rapid PCR-based testing in the diagnostic work-up of aseptic meningitis due to enterovirus. One of these studies found that rapid detection of enterovirus and appropriate clinical management during an outbreak of enterovirus meningitis in adults reduced the mean length of hospital stay from 103 to 80 h and reduced the mean duration of antibacterial treatment from 115 to 69 h (28) . Another study found that pediatric patients for whom positive enterovirus PCR results were available within 24 h had 20 h less of antibiotic treatment and US $2,798 less in hospital fees than patients with positive results available after 24 h (20) . Our real-time PCR assay for enterovirus has an assay time of approximately 4 h and thus should allow realization of such cost savings to the health care system. In summary, our laboratory has developed a rapid and highly sensitive real-time TaqMan assay for the quantification of enterovirus RNA in CSF. The assay is faster, safer, less expensive, and more specific than earlier assays based on liquidphase hybridization. Rapid and sensitive diagnosis of enterovirus infections should result in timely and appropriate management of patients presenting with clinical meningitis, with significant cost savings to the patient and the health care system.
